ClinicalTrials.Veeva

Menu

Laser Acupuncture for Idiopathic Bell's Palsy

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Bell Palsy

Treatments

Drug: Steroids
Device: Laser acupuncture
Device: Sham laser acupuncture

Study type

Interventional

Funder types

Other

Identifiers

NCT06732622
Laser-Bell-2025

Details and patient eligibility

About

Bell's palsy is characterized by acute, unilateral onset that compromises function and esthetics, exerting a considerable impact on the social, professional, and psychological aspects of the lives of affected individuals. The objective of this study was to determine whether laser acupuncture therapy could relieve symptoms in patients with Bell's palsy.

Full description

This study was randomized controlled trial including 360 patients that undergoing Bell's palsy. All the patients received oral Prednisolone. Patients were assigned to the laser acupuncture (LA) group, Sham LA group and control group, with 120 patients in each group. LA group and Sham LA group were received 4 weeks of Laser treatment (3 times per week).

Clinical outcome measure comprised the House-Brackmann grading system, Sunnybrook facial grading scale (SBFG), Facial Disability Index (FDI) and Facial Clinimetric Evaluation Scale (FaCE Scale) All the measurements were collected at the baseline, weeks 2, 4, 6, 8, 12 and 24.

Enrollment

360 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Patients diagnosed with idiopathic Bell's Palsy 2.Patients were eligible if they were graded at House-Brackmann grade (HB) 3 or higher.

Exclusion criteria

    1. Serious mental illness or social problems, and neurological disorders, and systemic diseases, such as malignant tumors, and other serious consumptive diseases. 2. Planning for pregnancy, those in pregnancy, or those who were lactating. 3.Bell's Palsy patients who have a disease course of more than 8 weeks.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

360 participants in 3 patient groups

Laser acupuncture Group
Experimental group
Treatment:
Device: Laser acupuncture
Drug: Steroids
Sham laser acupuncture Group
Sham Comparator group
Treatment:
Device: Sham laser acupuncture
Drug: Steroids
Control group
Other group
Treatment:
Drug: Steroids

Trial contacts and locations

1

Loading...

Central trial contact

Dong Wu, Doctor; Haihong Lian, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems